12.05.13
BioCell Technology, LLC, Newport Beach, CA, has been granted U.S. Patent 8,563,045 by the United States Patent and Trademark Office (USPTO) pertaining to the dietary ingredient BioCell Collagen. This is the company’s sixth U.S. patent. The latest patent on BioCell Collagen has key claims regarding molecular composition, molecular weight, and manufacturing method. It also covers the use of BioCell Collagen in various ingestible and topical applications, including but not limited to, methods of replenishing hyaluronic acid and chondroitin sulfate, restoring skin viscoelasticity, retaining skin moisture, and inducing cartilage formation.
BioCell Collagen is a patented nutraceutical ingredient comprised of naturally occurring hydrolyzed collagen type II, chondroitin sulfate, and hyaluronic acid in a matrix form. BioCell Technology utilizes a patented Bio-Optimization technology to reduce what are originally large molecules into small and bioavailable molecules that are easier for the body to absorb and deliver to key areas such as joints, skin, tendons and ligaments.
BioCell Collagen is a patented nutraceutical ingredient comprised of naturally occurring hydrolyzed collagen type II, chondroitin sulfate, and hyaluronic acid in a matrix form. BioCell Technology utilizes a patented Bio-Optimization technology to reduce what are originally large molecules into small and bioavailable molecules that are easier for the body to absorb and deliver to key areas such as joints, skin, tendons and ligaments.
